Comparison

DNAJC15 Antibody (Center) Blocking Peptide

Item no. ABC-BP13156c
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products DNAJC15, DnaJ homolog subfamily C member 15, DNAJD1, MCJ, Cell growth-inhibiting gene 22 protein, Methylation-controlled J protein
Available
Primary Accession
Q9Y5T4
Bio Background
DNAJC15 is absent or down-regulated in many advanced cases of ovarian adenocarcinoma, due to hypermethylation and allelic loss. Loss of expression correlates with increased resistance to antineoplastic drugs, such as cisplatin.
Bio References
Need, A.C., et al. Hum. Mol. Genet. 18(23):4650-4661(2009)Witham, J., et al. Int. J. Cancer 122(11):2641-2645(2008)Hatle, K.M., et al. Mol. Cell. Biol. 27(8):2952-2966(2007)Lindsey, J.C., et al. Int. J. Cancer 118(2):346-352(2006)Strathdee, G., et al. Carcinogenesis 25(5):693-701(2004)
Gene ID
29103
Gene Name
DNAJC15
Subtitle
Synthetic peptide
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP13156c was selected from the Center region of DNAJC15. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close